2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Global Water Resources, Inc. entered into an eighth modification of its revolving line of credit with The Northern Trust Company on August 28, 2026. The amendment extends the maturity to August 30, 2028 and raises the maximum borrowing to $30.0 million, though it drops to $25.0 million if the company completes any capital market activity such as an equity or debt offering.
Maximum borrowing rises from $20.0 million to $30.0 million under the revolving line of credit.
Scheduled maturity extended from May 18, 2028 to August 30, 2028.
Borrowing limit falls to $25.0 million if the company raises funds through any equity or debt offering after the amendment date.
Agreement dated August 28, 2026; the 8-K was signed August 31, 2026 by CFO Michael J. Liebman.
On August 27, 2026, Digi International entered into an amended and restated $350 million senior secured revolving credit agreement with BMO Bank N.A. as administrative agent. The new facility replaces a $250 million agreement dated December 7, 2023, which Digi paid off and terminated, and it matures on August 27, 2031. The company says the expanded capacity and lower pricing give it more financial flexibility for acquisitions, though the filing does not report any earnings or cash flow figures.
$350 million senior secured revolving facility, with an uncommitted accordion of the greater of $130 million or 100% of trailing four-quarter EBITDA, maturing August 27, 2031.
Replaces the $250 million revolving credit agreement dated December 7, 2023, which was paid off and terminated on August 27, 2026.
Term SOFR margins range from 1.25% to 2.625%, compared with 135 to 310 basis points under the prior facility, according to the press release.
Maximum total net leverage covenant increased from 3.0x to 3.50x; minimum interest coverage ratio of 3.00x is unchanged.
On August 31, 2026, Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, closed a $1.25 billion private offering of 1.875% exchangeable senior notes due September 15, 2032, including the full $150.0 million option. The company also repurchased about $225.0 million of its ordinary shares from note purchasers at $249.29 per share, paid from cash on hand under its July 2024 repurchase program, which reduces the remaining authorization. For shareholders, the filing adds a senior unsecured debt obligation guaranteed by the company and sets an exchange price of about $355.24 per share.
Notes total $1.25 billion in principal, carry a 1.875% interest rate, and mature September 15, 2032; the closing includes the full $150.0 million option.
Estimated net proceeds are approximately $1,226.4 million, which the company expects to use for general corporate purposes.
Initial exchange price is about $355.24 per ordinary share, a premium of about 42.5% over the August 26, 2026 closing price.
About $225.0 million of ordinary shares were repurchased at $249.29 each, the August 26, 2026 closing price, using existing cash on hand.
Kyntra Bio amended its royalty financing agreement with NQ Project Phoebus, L.P., lowering the maximum aggregate payments from $125 million to $65 million in exchange for a $42.6 million accelerated upfront payment. The company says the amendment and the FibroGen Europe bankruptcy together reduce its future liabilities by approximately $80 million, but pro forma cash, cash equivalents, investments, and accounts receivable fall to $53.1 million from $95.7 million as of June 30, 2026.
Maximum aggregate payments reduced from $125 million to $65 million, a $60 million reduction in payment obligations
$42.6 million upfront payment brings total payments to NQ Project Phoebus to $50 million, a full return of its invested capital
Remaining $15 million cap to be paid from 50% of Astellas revenue for EVRENZO sales in Europe and other Astellas territories excluding Japan
Pro forma cash and related balances of $53.1 million as of June 30, 2026; company expects cash runway into the fourth quarter of 2027
On August 28, 2026, FactSet amended its credit agreement with PNC Bank as administrative agent. The amendment extends the term loan maturity to August 28, 2029 and the revolving facility maturity to August 28, 2031, while increasing revolving commitments from $1.0 billion to $1.5 billion. For shareholders, the filing shows expanded and longer-dated borrowing capacity, though the filing does not state any borrowing drawn under the facilities.
Revolving commitments increased from $1.0 billion to $1.5 billion, with final maturity extended to August 28, 2031
Term loan facility of $375 million, with final maturity extended to August 28, 2029 and scheduled amortization removed
Credit spread adjustment of 0.10% removed for Daily Simple SONIA and Term SOFR borrowings
ADT Inc.'s subsidiaries borrowed $100 million of incremental first lien senior secured term A loans on August 28, 2026, under an amendment to their existing term loan credit agreement. Total term A loans outstanding rise to $520,312,500, and the company says the proceeds will fund general corporate purposes.
Incremental term A loans of $100,000,000 incurred on August 28, 2026, under Incremental Assumption and Amendment Agreement No. 2
Total first lien senior secured term A loans outstanding are $520,312,500 after the borrowing
Proceeds will be used for general corporate purposes; the borrowers' obligations under the existing agreement are unchanged
Fifth Third Bank, National Association, is administrative agent
PureCycle Technologies amended its $200 million revolving credit facility on August 28, 2026, extending the maturity date from September 30, 2027 to September 30, 2028. The company must also pay a maturity extension fee, and the filing does not state its amount.
Revolving Credit Facility of up to $200 million extended from September 30, 2027 to September 30, 2028
Company must pay a maturity extension fee under the Twelfth Amendment; the fee amount is not stated in the filing
Lenders Sylebra Capital Partners Master Fund and Sylebra Capital Menlo Master Fund are greater than 5% beneficial owners of the company
Cohen & Company's operating subsidiary replaced a $5,145,926.67 senior promissory note with a $5,000,000 amended and restated note held by JKD Capital Partners I LTD, an entity owned by board member Jack J. DiMaio, Jr. and his spouse. The new note carries 10% annual interest payable quarterly and matures August 31, 2027, with a higher 11% rate after an event of default.
Amended and restated note in the principal amount of $5,000,000, combining $2,625,409.50 of unpaid original principal and interest with $2,374,590.50 of new cash from the investor.
Interest accrues at 10% per year, payable in cash quarterly beginning November 30, 2026; principal due August 31, 2027.
Note cannot be prepaid before January 31, 2027; afterward, prepayment requires at least 31 days' written notice and carries no penalty.
The note is senior to the subsidiary's existing indebtedness, and the subsidiary may not take on new debt senior to it after August 31, 2026.
Camping World Holdings' subsidiaries entered into an amended and restated senior secured mortgage credit agreement with M&T on August 25, 2026, totaling $175.0 million in aggregate principal. The new facility replaces the prior facility and extends its maturity from October 27, 2027 to August 25, 2031, adding borrowing capacity and new loan terms for shareholders to track.
Facility totals $175.0 million: $132.8 million funded at closing and $42.2 million of delayed draw commitments available through February 25, 2031.
About $20.8 million was drawn at closing, net of fees and lender holdbacks, and the borrowers may request up to an additional $100.0 million.
Maturity extended to August 25, 2031, from October 27, 2027; amortization of 5.0% of original principal annually begins September 30, 2026.
Loans bear interest at term SOFR plus 2.30% or a base rate plus 1.30%, and require a debt service coverage ratio of at least 1.10 to 1.00.
Worthington Enterprises amended and restated its five-year, $500 million revolving credit facility on August 31, 2026, extending the final maturity from September 27, 2028 to August 31, 2031. The company had no borrowings and no letters of credit outstanding under the new agreement at the effective date, and the filing does not describe any change to commitment size, which remains $500 million.
Aggregate commitments remain $500 million; maturity extended to August 31, 2031
Company may request up to $300 million in incremental commitments or term loans, subject to lender consent
No borrowings or letters of credit outstanding as of August 31, 2026
Financial covenants: interest coverage at least 3.25 to 1.00; debt-to-capital no greater than 55%
On August 27, 2026, FirstCash signed the Tenth Amendment to its U.S. revolving unsecured credit facility with Wells Fargo Bank, National Association, as administrative agent. The amendment raises the total lender commitment from $700 million to $1.055 billion, extends the maturity from August 8, 2029 to August 27, 2031, and raises the permitted consolidated net leverage ratio to 3.5 times EBITDA for the full term. The company said the larger facility is intended to help fund the pending Ramsdens acquisition in the U.K. and other acquisitions.
Total lender commitment increased from $700 million to $1.055 billion.
Maturity extended from August 8, 2029 to August 27, 2031.
Borrowings allowed in U.S. dollars and pounds sterling, priced at SONIA or SOFR plus a 2.50% margin.
Permitted consolidated net leverage ratio increased to 3.5 times EBITDA; the Ramsdens acquisition is pending final regulatory approval.
GameStop amended its exchange agreements for about $1.4 billion of 0.00% convertible notes due 2030 and 2032, ending the remaining averaging period and settling the balance in cash. Existing noteholders will receive about 55.5 million shares and $358.4 million in cash, with closing expected on or about September 3, 2026. The company also gave preliminary second-quarter results showing net sales down from the prior year while operating income and net income are expected to rise.
Noteholders receive about 55.5 million shares (about 73%) and $358.4 million in cash (about 27%); the company says the share count is now fixed
Preliminary Q2 net sales of $780 million to $800 million, versus $972.2 million a year earlier
Preliminary Q2 operating income of $150 million to $170 million versus $66.4 million; net income of $290 million to $310 million versus $168.6 million
About $2.8 billion of notes remain outstanding after the exchange; complete Q2 results are due September 8, 2026
JATT III Acquisition Corp, a Cayman Islands blank check company, closed its initial public offering on August 27, 2026, selling 6.9 million ordinary shares at $10.00 each, including the full exercise of the underwriters' over-allotment option. The company also sold 234,000 private placement shares to its sponsor for $2.34 million, and the IPO and private placement proceeds were placed in a U.S.-based trust account, which holds the funds until a business combination, or redemption if none is completed within 24 months.
IPO closed August 27, 2026: 6.9 million ordinary shares at $10.00 each, for gross proceeds of $69 million before underwriting discounts and offering expenses
Private placement of 234,000 shares to sponsor JATT Ventures III L.P. at $10.00 per share, for $2.34 million
Trust account holds $69 million; funds are released only on a business combination or on redemption if none is completed within 24 months of the IPO closing
Four independent directors appointed August 25, 2026; Mr. Badial chairs the Audit Committee
Deckers Outdoor entered into a First Amendment to its credit agreement with Citibank, N.A. as administrative agent, effective August 27, 2026. The amendment increases unsecured revolving commitments to $500 million, extends the maturity to August 27, 2031, and lowers the commitment fee on unused amounts. The filing says proceeds will be used for working capital and general corporate purposes.
Unsecured revolving commitments increased to $500 million
Maturity extended to August 27, 2031, subject to lender extension conditions
Commitment fee on unused amounts now 0.10% to 0.175% per annum, based on total net leverage ratio
Benelux subsidiary Deckers Benelux B.V. released as a borrower
Spero Therapeutics entered an at-the-market share sale agreement with Jefferies LLC as agent on August 28, 2026, allowing it to sell common stock up to $100 million once its $300 million universal shelf registration statement is declared effective. The company also terminated its prior Cantor Fitzgerald at-the-market agreement effective the same day, with no termination penalties and no shares sold under that agreement in fiscal 2024 or 2025. Shareholders could face dilution if the company sells shares under the new agreement, but the filing states no amount has been sold and no sales can occur until the registration is effective.
Agreement with Jefferies allows sales of up to $100 million of common stock under the prospectus once the registration statement is effective
Jefferies compensation is up to 3.0% of gross proceeds from shares sold
Shelf registration on Form S-3 covers up to $300 million in debt securities, common stock, preferred stock and other securities
Cantor Fitzgerald sales agreement terminated effective August 28, 2026, with no termination penalties and no shares sold in fiscal 2024 or 2025
On August 26, 2026, RenX Enterprises sold $5,662,716.07 in second senior convertible notes and second warrants in a private placement, with net proceeds of about $5.4 million after fees. The company used the proceeds to repay its February notes at 110% of their outstanding principal, and amended the related agreements to change registration deadlines and liquidated damages terms. The filing shows added debt and potential dilution from conversion and warrant shares, though it does not state a financial result.
Second Notes principal of $5,662,716.07 issued August 26, 2026; net proceeds of about $5.4 million
Up to 11,664,772 shares issuable on conversion at the Floor Price, and 3,520,859 shares under Second Warrants
Proceeds used to repay February Notes at 110% of outstanding principal
Second Registration Statement due 15th calendar day after the Second Closing Date
Coherus Oncology entered an at-the-market sales agreement with Leerink Partners allowing it to sell up to $50.0 million of common stock from time to time, at its discretion. The company is not obligated to sell any shares, and it will pay the agent a commission of up to 3.0% of gross proceeds, so the program could dilute existing holders if used.
Sales Agreement with Leerink Partners LLC dated August 28, 2026, covering up to $50.0 million in common stock
Agent commission of up to 3.0% of gross proceeds from each sale
Shares offered under Form S-3 shelf registration declared effective December 8, 2025
Net proceeds intended for general corporate purposes, including working capital
Katapult Holdings' subsidiary CCF OpCo LLC signed a Sixth Amendment to its revolving credit agreement with lenders led by The Huntington National Bank as administrative agent. The amendment extends the scheduled Draw Period Termination Date from August 30, 2026 to September 30, 2026, giving the borrower an extra month to draw on the facility. The filing does not state the facility size or any change in terms beyond the date.
Draw Period Termination Date extended from August 30, 2026 to September 30, 2026
Early termination is possible upon an unwaived Cease Funding Event, and further extensions require lender approval
After a Draw Period Termination Date, a twelve-month amortization period starts, with maturity deferred to its end absent an Event of Default
Amendment is filed as Exhibit 10.1; signed by CFO Russell Falkenstein
On August 24, 2026, Boeing entered a $3.0 billion 364-day revolving credit agreement with Citibank and JPMorgan, replacing a facility that was due to terminate that day. The company also amended its 2024 and 2023 five-year credit agreements to extend their terms and add a minimum liquidity covenant of $5.0 billion. The filing describes committed borrowing capacity and does not state any amounts drawn.
The new $3.0 billion 364-day facility is scheduled to terminate on August 23, 2027, with fees of 0.125% to 0.300% per annum on commitments depending on Boeing's credit rating.
The 2024 Five-Year Credit Agreement ($4.0 billion in commitments) now terminates May 15, 2030; the 2023 Five-Year Credit Agreement ($3.0 billion) now terminates August 24, 2029.
The agreements add or keep covenants including minimum liquidity of at least $5.0 billion and consolidated debt not exceeding 60% of total capital.
Rainier Acquisition Corporation, a special purpose acquisition company focused on global life sciences, closed its initial public offering on August 28, 2026, selling 7,500,000 units at $10.00 per unit for gross proceeds of $75,000,000 before underwriting discounts and offering expenses. The company placed $75,000,000 in a trust account, and the filing states that trust funds generally stay there until a business combination is completed or specified redemption events occur, with a 24-month deadline from the IPO closing to complete a business combination. Shareholders should note that the filing reports the IPO closing and related agreements, not any target business or acquisition agreement.
IPO closed August 28, 2026: 7,500,000 units at $10.00 each, $75,000,000 gross proceeds; units began trading as RNAQU on Nasdaq Capital Market on August 27, 2026
$75,000,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company; the company has 24 months from IPO closing to complete an initial business combination
Sponsor Ravenna 7 LLC agreed to buy 194,375 private placement units at $10.00 each; underwriters hold a 45-day option for up to 1,125,000 additional units
Wing C. Lam, PharmD and Chidozie Ugwumba were appointed to the board on August 26, 2026; Ugwumba chairs the audit committee
Choice Hotels International entered a $500 million unsecured term loan under a credit agreement with Wells Fargo Bank as administrative agent, dated August 28, 2026. The company says proceeds are expected for general corporate purposes, including working capital and debt repayment. The loan adds $500 million of direct debt and comes with covenants limiting dividends and stock repurchases, which may affect shareholder payouts.
$500 million unsecured term loan with scheduled maturity on August 28, 2029, plus an optional one-year extension subject to lender consent
Interest at SOFR (0.00% floor) plus 1.25%, or a base rate plus 0.25%, at the company's election
Financial covenants require a fixed charge coverage ratio of at least 2.5 to 1.0 and a leverage ratio of not more than 4.5 to 1.0, with the fixed charge coverage requirement waived while the company holds an Investment Grade Rating
Agreement restricts dividends and stock repurchases, and the filing lists Wells Fargo Bank, National Association as administrative agent
Pool Corporation subsidiaries signed Amendment No. 14 to their receivables securitization facility on August 25, 2026, extending the facility termination date to August 25, 2028. The maximum limit is $400 million from March through September and $300 million in the remaining months, with borrowings priced at one-month Term SOFR plus 0.75% or 0.85%, depending on tranche.
Termination date extended to August 25, 2028, with the agreement effective August 25, 2026
Maximum facility limit of $400 million (March through September): $300 million committed and $100 million uncommitted
Maximum limit of $300 million ($200 million committed and $100 million uncommitted) in the other months of the year
Interest at one-month Term SOFR plus 0.75% (committed) or 0.85% (uncommitted); Wells Fargo Bank, National Association is administrative agent
Pluri Inc. agreed on August 26, 2026, to sell 1,200,000 common shares and pre-funded warrants for up to 1,028,940 shares in a registered direct offering, with a concurrent private placement of common warrants for 2,228,940 shares. The offering is expected to close on August 28, 2026, with estimated net proceeds of about $2,984,808 for corporate development, general purposes and working capital. The sale adds shares and warrant exercise rights that could dilute existing shareholders.
Shares priced at $1.50 each; pre-funded warrants priced at $1.49999 with a $0.00001 exercise price
Common warrants exercisable at $1.65 per share, initially six months after issuance, for five years
Placement agent A.G.P./Alliance Global Partners receives a 6.50% cash fee on gross proceeds
Directors and executive officers and the company face 45-day restrictions on new share issuances and sales
JBG SMITH Properties LP entered into a Second Amended and Restated Credit Agreement with Bank of America on August 27, 2026, providing a $690.0 million senior unsecured revolver maturing August 27, 2030, with $230.0 million drawn as of that date. The company also amended two Wells Fargo term loans and its $120.0 million 2023 Term Loan to align covenants with the new revolver, extending part of a $400.0 million term loan to August 25, 2028.
$690.0 million revolving facility replaces the $750.0 million Existing Credit Agreement, which was due June 29, 2027; $230.0 million was drawn as of August 27, 2026
Revolver matures August 27, 2030, with two six-month extension options at a 0.075% fee each
$228.9 million of the $400.0 million Tranche A-2 term loan was extended to August 25, 2028; $171.1 million remains due January 13, 2028, and the term loan was increased by $15.0 million
Financial covenants include total indebtedness to property valuation of not more than 60% and EBITDA to fixed charges of at least 1.50 to 1.00
Southern Cross Acquisition II Corp., a blank check company, closed its initial public offering on August 27, 2026, selling 7,652,630 units at $10.00 each for gross proceeds of $76,526,300. About $76,717,616 from the IPO and private unit sale was placed in a trust account, and access to those funds is restricted until a business combination or other specified events occur. The company also appointed three independent directors and adopted amended and restated articles of association.
Closed IPO on August 27, 2026 of 7,652,630 units at $10.00 per unit, including a partial over-allotment of 152,630 units, for gross proceeds of $76,526,300.
Sold 224,932 private units to the Sponsor and D. Boral Capital LLC for $2,249,320.
About $76,717,616 placed in the trust account; funds are not released until a business combination, a shareholder redemption event, or failure to complete a business combination within 12 months.
Hongmei Zhao, Wenhua Qian and Zhiqiang Du became independent directors effective August 26, 2026.
Avidbank Holdings sold $30 million of 7.00% fixed-to-floating subordinated notes due September 1, 2036, under an agreement dated August 26, 2026, with institutional purchasers. The company plans to use the proceeds to redeem its $22 million of 5.000% subordinated notes due 2029 and for general corporate purposes, and on August 27, 2026 it repurchased $18 million of those 2029 notes and called the remaining $4 million for September 30, 2026.
$30 million of notes sold at 100% of face amount, fixed at 7.00% until September 1, 2031, then resetting quarterly to three-month term SOFR plus 291 basis points
On August 27, 2026, $18 million of the 2029 notes were repurchased for about $18.2 million, including accrued interest; the remaining $4 million is to be redeemed on September 30, 2026
The notes are unsecured, subordinated obligations, are intended to qualify as Tier 2 regulatory capital, and were sold in a private placement with Piper Sandler & Co. as sole placement agent
Perma-Pipe International Holdings entered into a new secured credit agreement with J.P. Morgan on August 25, 2026, replacing its existing credit agreement, which was terminated and repaid in full. The facility includes a $75.0 million revolver and a $14.0 million term loan, with up to $50.0 million of additional capacity available on request, and matures August 25, 2031. The filing describes the change as consolidating multiple facilities into one global arrangement, and it adds covenants on leverage and fixed charge coverage.
Facility: $75.0 million revolving credit line and $14.0 million term loan, maturing August 25, 2031
At closing, the company borrowed $14.0 million under the term loan and had $23.0 million outstanding under the revolver
Replaced the existing credit agreement, with proceeds and other cash used to repay its borrowings in full
Requires a leverage ratio of no more than 3.00 to 1.00 and a fixed charge coverage ratio of at least 1.25 to 1.00
Core Scientific entered into a credit agreement on August 25, 2026, providing a $100 million revolving credit facility and a $500 million letter of credit facility, with no amounts outstanding at closing. The company said the facilities are expected to release about $300 million of restricted cash, which management says will improve capital efficiency and financial flexibility. The agreement is secured by substantially all company assets and carries covenants limiting debt, liens, dividends and share repurchases.
Credit agreement dated August 25, 2026, with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent
$100 million revolving facility matures in three years, or four at the company's election; $500 million letter of credit facility
Revolver borrowings priced at Adjusted Term SOFR plus 1.75% or alternate base rate plus 0.75%; no amounts outstanding at closing
Company expects the facilities to release approximately $300 million of restricted cash, per CFO Jim Nygaard
On August 26, 2026, Jupiter Neurosciences' chairman and CEO, president and COO, chief scientific officer, and chief administrative officer irrevocably forgave $875,315 of accrued, unpaid compensation owed to them by the company. The filing says the forgiveness was gratuitous, with no equity issued and no cash or other consideration paid, so the change removes liabilities from the balance sheet without a cash outlay.
Total forgiven: $875,315 of accrued salaries reflected as liabilities on the balance sheet
Christer Rosén (Chairman and CEO and Director) forgave $356,024; Marshall Hayward, Ph.D. (Chief Scientific Officer and Director) forgave $287,075
Alison Silva (President, COO and Director) forgave $81,431; Alexander Rosén (Chief Administrative Officer) forgave $150,785
Effective August 26, 2026; the company issued no equity or cash in exchange, and each agreement includes a general release of related claims
Serina Therapeutics entered into a Common Stock Purchase Agreement and a Registration Rights Agreement with Roth Principal Investments, both dated August 21, 2026. The company can choose, at its sole discretion, to sell up to $25 million of newly issued common stock over up to 36 months, so the deal gives it a funding option while adding potential dilution at prices set below market.
Agreement dated August 21, 2026 allows the company to sell up to $25 million of newly issued common stock to Roth Principal Investments, at the company's option and with no obligation to sell.
Purchases are priced at a discount to volume weighted average price: 7% before cumulative sales reach $12.5 million and 3% after, for market open and intraday purchases.
Under NYSE American rules, issuance is capped at 5,077,554 shares, equal to 19.99% of shares outstanding before signing, unless stockholders approve more or other conditions are met.
Sales can begin only after a resale registration statement is declared effective by the SEC, and the company may direct purchases for up to 36 months from that Commencement Date.
Biomerica agreed on August 20, 2026 to sell 1,393,705 common shares at $1.60 each to institutional and individual investors, including B. Riley Principal Capital and some directors and executive officers, for gross proceeds of about $2.23 million; the deal closed August 26, 2026. The filing also gives B. Riley purchasers a board designation right while they hold at least 10% of voting power, and requires registration of the resale of the shares, with liquidated damages if deadlines are missed.
1,393,705 shares sold at $1.60 per share, about $2.23 million gross proceeds
Closing occurred August 26, 2026; agreement dated August 20, 2026
B. Riley purchasers may designate one board representative while holding at least 10% of voting power
Directors and certain officers face 180-day lock-up; company must file resale registration within 30 days of closing
Northern Oil and Gas, Inc. (NOG) issued $500 million in aggregate principal amount of 7.500% Senior Notes due September 1, 2034, under an indenture with Wilmington Trust, National Association, as trustee. The company can redeem up to 40% of the notes before September 1, 2029 using equity offering proceeds, and holders can require repurchase at 101% of principal upon a change of control.
Notes: $500 million, 7.500% coupon, maturing September 1, 2034; interest paid semi-annually from March 1, 2027
Early redemption before September 1, 2029 at 107.500% of principal from equity offering proceeds, or at 100% plus a make-whole premium
Redemption prices from September 1, 2029: 103.750% in 2029, 101.875% in 2030, 100.000% in 2031 and after
Indenture covenants limit debt, dividends, asset sales and mergers; the covenants end if the notes reach investment grade
LeonaBio said it has enrolled the 500th subject in its Phase 3 ELAINE-3 trial of lasofoxifene with abemaciclib in ESR1-mutated metastatic breast cancer. The filing also sets the start of the exercise window for 23,031,494 Series A Common Warrants at $6.35 per share, which could bring about $146.2 million in cash if fully exercised, and states that the enrollment announcement triggers that window.
500th subject enrolled in the ELAINE-3 Trial (NCT05696626), announced August 26, 2026
23,031,494 Series A Common Warrants with an exercise price of $6.35 per share, issued in connection with the December 2025 Private Placement
Warrants become exercisable after the latest of June 30, 2026, this announcement, and FDA action on Eli Lilly's imlunestrant with abemaciclib, and no later than October 31, 2026
Full exercise would provide approximately $146.2 million; warrants expire no later than November 30, 2026
Following the August 19, 2026 closing of the Cox transaction, Cox entities became guarantors of and granted liens on assets securing Charter's debt, as well as several Cox note indentures. Under the filing, secured notes across the combined Charter and Cox capital structure now share the same collateral and obligors on a pari passu basis, which changes the security package behind existing debt rather than adding new borrowing.
On August 19, 2026, Charter completed the Transaction with Cox Enterprises, acquiring Cox's commercial fiber and managed IT and cloud services businesses.
On August 24, 2026, Cox entities became guarantors and granted liens under the Charter Credit Agreement with Bank of America, N.A. as administrative agent.
Supplemental indentures dated August 24, 2026 add guarantors to the CCO, Cox, TWC and TWCE indentures, with The Bank of New York Mellon as trustee.
The filing does not state a new principal amount of debt or a dollar figure for the guarantees.
The closed-end fund entered into a distribution agreement with ALPS Distributors allowing it to sell up to $75 million of common shares over time through the market, and began the offering on August 25, 2026. Shares may not be sold below net asset value, and the Fund pays the distributor a 1.00% commission on gross sales, so new share issuance could dilute existing holders.
Program size: up to $75,000,000 of common shares with no par value, offered at the market through ALPS Distributors, Inc.
Sub-placement agent UBS Securities LLC was engaged under a sub-placement agreement dated August 25, 2026.
The Fund pays the distributor a commission equal to 1.00% of gross sales price per share sold.
Offering made under a prospectus supplement dated August 25, 2026 and a base prospectus dated August 7, 2026 on Form N-2 (File No. 333-298123).
Karman Line Acquisition Corp., a blank check company, completed its initial public offering of 20,000,000 units at $10.00 per unit on August 19, 2026, with $200 million placed in a trust account for public shareholders. The filing names Karman Line, not Xterax Corp II, so it could not be matched to the XTER ticker in the document; the company has not yet selected a business combination target.
IPO of 20,000,000 units at $10.00 per unit completed August 19, 2026, with $200 million placed in trust
Private placement of 650,000 units at $10.00 per unit, generating $6.5 million gross proceeds
Trust funds can be released only for a business combination, taxes, or redemptions; otherwise redeemed if no deal within 21 months
Audited balance sheet as of August 19, 2026 shows $2.5 million cash and $8 million deferred underwriting commissions
Tractor Supply Company issued and sold $500 million of 5.200% senior unsecured notes due January 30, 2032, on August 25, 2026, under an underwriting agreement dated August 19, 2026. The company said it intends to use the net proceeds to repay borrowings under its senior credit facility and for general corporate purposes, so the offering adds long-term debt while shifting borrowings from the credit facility to fixed-rate notes.
$500 million principal of 5.200% senior notes issued August 25, 2026, under an underwriting agreement dated August 19, 2026, with Wells Fargo Securities and BofA Securities as representatives
Interest is paid semi-annually on January 30 and July 30, starting January 30, 2027; maturity is January 30, 2032
Net proceeds will repay borrowings under the senior credit facility and fund general corporate purposes; some underwriter affiliates are lenders under that facility and will receive at least 5% of net proceeds
Before December 30, 2031, the company may redeem the notes at the greater of par or a Treasury-based price plus 15 basis points; holders may require repurchase at 101% of principal upon a change of control triggering event
Ryman Hospitality Properties and its operating partnership issued $700 million of 6.250% Senior Notes due 2035 under a new indenture dated August 25, 2026. Proceeds are intended to help fund an approximately $1.38 billion acquisition of the JW Marriott Orlando Grande Lakes Resort and The Ritz-Carlton Orlando, Grande Lakes, with the rest coming from a recent stock offering and cash on hand. The added debt increases the company's borrowing obligations, and the notes must be redeemed if the acquisition is not completed.
$700 million aggregate principal of 6.250% Senior Notes due February 15, 2035
Proceeds intended to fund part of an approximately $1.38 billion purchase of the Orlando Grande Lakes properties
Balance funded by proceeds of a 5,865,000-share offering at $117.00 per share, closed August 12, 2026, and cash on hand
Notes subject to special mandatory redemption at 100% of issue price plus accrued interest if the acquisition is not completed
B&R Technology Merger Corp. said the underwriter partially exercised its over-allotment option on August 24, 2026, buying 3,500,000 additional units at $10.00 each for $35 million. Total units sold in the initial public offering rose to 36,000,000, with $360 million placed in a U.S.-based trust account, and the underwriter forfeited the remaining option.
August 24, 2026: 3,500,000 over-allotment units sold at $10.00 per unit, for $35,000,000 in additional gross proceeds
Total IPO: 36,000,000 units and $360,000,000 in gross proceeds, with $360,000,000 placed in trust with Continental Stock Transfer & Trust Company
Sponsor bought 52,500 additional private placement units for $525,000; 458,333 Class B shares were surrendered and cancelled
Remaining option for 1,375,000 units was forfeited
DraftKings closed a second amendment to its credit agreement on August 25, 2026, adding a $700 million Term Loan B due 2033 and a $750 million revolving credit facility maturing in 2031. The revolver replaces an existing $500 million facility scheduled to mature in November 2029. The company plans to use the term loan proceeds to repurchase part of its 0% convertible notes due 2028, subject to market conditions, and for general corporate purposes.
Term Loan B of $700 million, up from the previously announced $600 million, due August 2033, priced at Term SOFR plus 2.00% and offered at 99.50% of par
New $750 million revolving credit facility maturing August 25, 2031, replacing the $500 million facility due 2029
Planned use of term loan proceeds: repurchases of part of the 0% Convertible Senior Notes due 2028, subject to availability and market conditions
Marten Transport amended its unsecured revolving credit agreement on August 19, 2026, extending the term to August 19, 2031 and raising the letter of credit sublimit to $50 million. The amendment also lowers the maximum aggregate principal amount to $100 million from $105 million and updates the margins for Term SOFR advances. For shareholders, the filing shows a longer borrowing term and a smaller maximum facility size, and the full Second Amendment will be filed with the next Form 10-Q.
Second Amendment dated August 19, 2026 extends the credit agreement term to August 19, 2031.
Letter of credit sublimit increases to $50 million from $35 million.
Maximum aggregate principal amount decreases to $100 million from $105 million; a Second Amended and Restated Revolving Note allows up to $50 million.
Full Second Amendment will be attached to Marten's next Quarterly Report on Form 10-Q.
Credit Acceptance completed a $600.0 million asset-backed, non-recourse secured financing dated August 20, 2026, backed by consumer loans with a value of about $750.2 million. The company expects an average annualized cost of about 5.5% including upfront fees, and will use the proceeds to repay higher-cost debt and for general corporate purposes.
Three note classes: A $319.9 million at 5.01%, B $117.3 million at 5.29%, C $162.8 million at 5.51%
Financing revolves for 24 months, then amortizes based on cash flows from the conveyed loans
Company says it had about $1.8 billion in unused revolving credit capacity and unrestricted cash after the deal
Debt is non-recourse to the company, apart from limited repurchase and indemnification obligations
BTCS Inc. disclosed on August 25, 2026 that on August 21, 2026 it borrowed an additional $10.0 million in USDT from the AAVE protocol, bringing total AAVE borrowings to about $53.0 million. The loan is collateralized by about 46,531 ETH valued at $112.6 million and can be partially or fully liquidated if the health factor falls below one, so the added debt increases the company's exposure to collateral value and liquidation risk.
Additional borrowing of $10.0 million in USDT on August 21, 2026; total AAVE borrowings about $53.0 million.
Collateral is about 46,531 ETH, approximately $112.6 million at an ETH price of $2,420.
Variable interest rate was about 3.98% per annum at the time of the new borrowing; no fixed maturity date.
Loan proceeds were used to buy additional ETH and USDC, deployed into liquidity pools through the Imperium business.
Boxlight amended its inventory finance agreement with J.J. Astor, a related party whose CEO is the chairman of Boxlight's board, Michael Pope. Under two amendments, the company converted $75,608.38 and $92,357.55 of the outstanding balance into common stock at $2.49615 per share. The filing shows the debt reduction and the new share issuance, which increases the number of shares outstanding.
August 17, 2026: $75,608.38 of debt converted into 30,290 shares at $2.49615 per share under the Second Amendment
August 19, 2026: $92,357.55 of debt converted into 37,000 shares at $2.49615 per share under the Third Amendment
J.J. Astor is beneficially owned by a private investment fund managed by Michael Pope, chairman and principal executive officer of Boxlight
The inventory finance agreement was originally dated May 27, 2025, amended and restated November 3, 2025, and previously amended April 1, 2026
Madison Air Solutions agreed to sell 90,108,130 Class A common shares at $24.97 each in a private placement expected to bring in about $2.25 billion before fees, with closing expected on or about September 1, 2026. The company says the proceeds will fully fund the equity portion of its acquisition of ebm-papst entities, for which estimated total cash payable at closing is $5.0 billion. Chairman Larry Gies and an affiliated entity, Madison Solutions LLC, are buying a combined $620.0 million of the shares, and the filing notes the sale may dilute existing stockholders.
Sale of 90,108,130 Class A shares at $24.97 per share, with gross proceeds expected to be about $2.25 billion
Larry Gies agreed to buy $300.0 million of shares; Madison Solutions LLC agreed to buy $320.0 million
Expected closing on September 1, 2026; proceeds fund the equity portion of the ebm-papst acquisition, with estimated total cash payable at closing of $5.0 billion
Shares must be registered for resale within 90 calendar days after closing; Gies and Madison Solutions shares are locked up for one year
Singularity Future Technology Ltd. sold common stock and pre-funded warrants in two registered direct offerings, dated August 18 and August 20, 2026, for gross proceeds of about $1.8 million and $5.0 million before fees and expenses. The company will use the proceeds for working capital and, in the second offering, its planned data center business, and the new shares and warrants add to the share count shareholders own.
First offering, closed August 19, 2026: 340,000 common shares at $3.00 each plus pre-funded warrants for 260,000 shares, for about $1.8 million gross.
Second offering, closed August 21, 2026: 451,250 common shares at $3.20 each plus pre-funded warrants for up to 1,111,250 shares, for about $5.0 million gross.
Placement agent Univest Securities LLC receives a fee of 7% of gross proceeds, and the company agreed not to issue more shares or file new registration statements for 30 days after the closings.
The Purchaser's right to buy up to an additional 100% of its first-offering shares, which ran through September 18, 2026, was terminated.
Ensysce Biosciences said its first tranche of a Series C Preferred Stock financing, totaling roughly $43 million, closed on August 7, 2026, raising more than $21 million in gross proceeds. The company believes this restores compliance with Nasdaq's minimum stockholders' equity requirement and that it qualifies for a second 180-day grace period to regain compliance with the $1.00 bid price rule.
First tranche closed August 7, 2026, raising more than $21 million gross; total financing is about $43 million for 120,260 Series C Preferred shares
Second tranche depends on a clinical trial milestone that has not yet occurred
Company believes stockholders' equity is at least $2.5 million, meeting the Nasdaq Rule 5550(b)(1) requirement, pending Nasdaq confirmation
Second 180-day bid price grace period was requested from Nasdaq on August 24, 2026; Nasdaq response is pending
Jupiter Neurosciences sold 307,692 shares at $6.50 each in a registered direct offering that closed August 24, 2026, for gross proceeds of about $2.0 million before fees and expenses. The company believes the sale brings its stockholders' equity above the $2.5 million Nasdaq continued-listing requirement, but it is still waiting for Nasdaq's formal confirmation, and its shares may face delisting if compliance is not shown at its next periodic report.
Shares issued: 307,692 common shares at $6.50 each, under an agreement dated August 21, 2026
Gross proceeds: approximately $2.0 million before placement agent fees and offering expenses, closed August 24, 2026
Nasdaq stockholders' equity requirement: $2.5 million; company awaiting formal determination of compliance
Delisting risk remains if compliance is not evidenced at the next periodic report
Backblaze issued $201.25 million of 0.00% convertible senior notes maturing August 15, 2031, including the full $26.25 million option exercised by the initial purchasers. The notes can convert into cash, Class A common stock, or both at the company's election, at about $21.94 per share, a 30% premium to the $16.88 closing price on August 19, 2026. The new debt could dilute existing shareholders if converted, though the company also bought capped call transactions, at a cost of about $17.5 million, that are intended to reduce that dilution.
Notes totaling $201.25 million were issued August 24, 2026, including the $26.25 million option exercised in full.
Initial conversion price is about $21.94 per share, a 30% premium to the $16.88 closing price on August 19, 2026.
Capped call transactions cost about $17.5 million, with a cap price of $33.76 per share.
The revolving credit facility rose from $20 million to $50 million and its maturity was extended from June 4, 2028 to April 30, 2030.
On August 24, 2026, Charter Communications Operating and its co-issuer completed the final settlement of their exchange offers for senior secured notes, issuing additional 2038 and 2041 notes in exchange for older notes. The exchanges swap existing debt for new 7.087% and 7.337% senior secured notes, so the filing shows a refinancing of existing obligations rather than new borrowing in cash.
Final Settlement Date was August 24, 2026, after the offers expired at 5:00 p.m. New York City time on August 20, 2026.
Issued $55,928,000 in additional 7.087% Senior Secured Notes due 2038 in exchange for $84,390,000 of Pool 1 notes.
Issued $35,750,000 in additional 7.337% Senior Secured Notes due 2041 in exchange for $60,634,000 of Pool 2 notes.
New notes are senior secured and mature in 2038 and 2041, with interest payable each March 1 and September 1, starting March 1, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.